1. Home
  2. Article
  3. Article Details Page
Skip to main content
eLearning on BoehringerOne

Diabetes and kidney disease & EMPA-REG explained and the role of Empagliflozin

Presenters

Prof. James A. Ker
Pulmonologist
Prof. James A. Ker
  • 2 CPD points upon completion (min pass rate 70%)

The article highlights the prevalence and impact of diabetic kidney disease on patients with diabetes. It emphasizes the need for a comprehensive approach to managing type 2 diabetes that includes lifestyle management, lipid treatment, blood pressure control, strict glycemic control, and the use of specific drugs like SGLT2 inhibitors.